HLA-B7 IN PRESUMED OCULAR HISTOPLASMOSIS MACULOPATHY

被引：0
|
作者：
GODFREY, WA
CROSS, DE
ZIEMIANSKI, MC
SABATES, R
机构：
[1] UNIV KANSAS, MED CTR, SCH MED, DEPT MED, KANSAS CITY, KS 66103 USA
[2] UNIV MISSOURI, SCH MED, MIDWEST ORGAN BANK, KANSAS CITY, MO 64110 USA
[3] UNIV KANSAS, MED CTR, SCH MED, DEPT OPHTHALMOL, KANSAS CITY, KS 66103 USA
来源：
TRANSPLANTATION PROCEEDINGS | 1979年 / 11卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1874 / 1876
页数：3
相关论文
共 50 条
  • [41] A REANALYSIS OF THE HLA-B7 CROSS-REACTIVE GROUP
    DARKE, C
    TISSUE ANTIGENS, 1983, 22 (05): : 326 - 334
  • [42] HLA-B7 AND ANKYLOSING-SPONDYLITIS IN AMERICAN BLACKS
    KHAN, MA
    KUSHNER, I
    BRAUN, WE
    SCHACTER, BZ
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (09): : 513 - 513
  • [43] INTERFERON TREATMENT OF HLA-A3, HLA-B7 HUMAN T LYMPHOMA AND MURINE TRANSFECTED L-CELLS RESULTS IN PREFERENTIAL ENHANCEMENT OF HLA-B7 EXPRESSION
    HAKEM, R
    PREVOT, C
    BARAD, M
    TRUJILLO, M
    MERCIER, P
    LEMONNIER, FA
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 265 - 266
  • [44] DIFFERENCES IN THE REGULATION OF HLA-A2 AND HLA-B7 ANTIGEN EXPRESSION BY INTERFERON
    SCHMIDT, H
    HEIDEMANN, E
    MULLER, C
    BLUT, 1985, 51 (03): : 230 - 231
  • [45] FINE SPECIFICITY OF HUMAN HLA-B7-SPECIFIC CYTOTOXIC LYMPHOCYTE-T CLONES .1. IDENTIFICATION OF HLA-B7 SUBTYPES AND HISTOTOPES OF THE HLA-B7 CROSS-REACTING GROUP
    VANSEVENTER, GA
    HUIS, B
    MELIEF, CJM
    IVANYI, P
    HUMAN IMMUNOLOGY, 1986, 16 (04) : 375 - 389
  • [46] VITREOUS HEMORRHAGE SECONDARY TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME
    KRANIAS, G
    ANNALS OF OPHTHALMOLOGY, 1985, 17 (05): : 295 - &
  • [47] LINEAR STREAKS OF THE EQUATOR IN THE PRESUMED OCULAR HISTOPLASMOSIS SYNDROME
    FOUNTAIN, JA
    SCHLAEGEL, TF
    ARCHIVES OF OPHTHALMOLOGY, 1981, 99 (02) : 246 - 248
  • [48] Aetiological study of the presumed ocular histoplasmosis syndrome in the Netherlands
    Ongkosuwito, JV
    Kortbeek, LM
    Van der Lelij, A
    Molicka, E
    Kijlstra, A
    de Smet, MD
    Suttorp-Schulten, MSA
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (05) : 535 - 539
  • [49] Therapy of Presumed Ocular Histoplasmosis Syndrome (POHS) with Bevacizumab
    Wildner, K.
    Koenigsdoerffer, E.
    Voigt, U.
    Augsten, R.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (02) : 195 - 197
  • [50] MICA association with presumed ocular histoplasmosis syndrome (POHS)
    Reinders, J
    Rozemuller, E
    Ongkosuwito, J
    Jager, M
    Tilanus, M
    Suttorp-Schulten, M
    MOLECULAR VISION, 2003, 9 (54): : 420 - 424
12345